AterianNASDAQ: ATER

Aterian, Inc. (NASDAQ:ATER ) Q3 2024 Earnings Conference Call November 11, 2024 5:00 AM ET Company Participants Ilya Grozovsky - VP, IR & Corporate Development Arturo Rodriguez - CEO Josh Feldman - CFO Conference Call Participants Brian Kinstlinger - Alliance Global Partners Alex Furman - Craig Hallum Capital Group Marvin Fong - BTIG Operator Thank you for standing by. My name is Bella and I will be your conference operator today.

Third Quarter Net Loss Improved by 71.7% Year Over Year Achieved Adjusted EBITDA Profit for the Second Consecutive Quarter, Marking a $4.9 Million Improvement Year-Over-Year SUMMIT, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the third quarter ended September 30, 2024.

SUMMIT, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its third quarter 2024 financial results after the market close on Monday, November 11, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.

Aterian, Inc. (NASDAQ:ATER ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, Investor Relations & Corporate Development Arturo Rodriguez - Chief Executive Officer Josh Feldman - Chief Financial Officer Conference Call Participants Brian Kinstlinger - Alliance Global Partners Alex Furman - Craig Hallum Capital Group Operator Thank you for standing by. My name is Kathy and I will be your conference operator today.

Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Between a Loss of ($1.0) Million to $0.0 Million NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the appointment of Arturo (Arty) Rodriguez as Chief Executive Officer (previously the Company's Co-CEO and CFO) and Josh Feldman as Chief Financial Officer (previously the Company's SVP of Finance) and that Joe Risico has resigned as Co-CEO and from the Board of Directors and will consult the Company over a three month transition period. “On behalf of our Board of Directors, we express our deep gratitude for Joe's passion, innovative ideas, and relentless work ethic.

NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has closed its acquisition of Contract Pharmaceuticals Limited Canada (“CPL” or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. Based in Mississauga, Ontario, Canada, CPL is an industry leader with longstanding relationships with 15 of the top.

Aterian, Inc. (Nasdaq: ATER) ("Aterian") stated that it will release its financial results for the first quarter of 2024 after the market closes on Tuesday, May 7, 2024. Additionally, it will hold a conference call for investors and interested parties at 5:00 p.m. ET on the same day.

Aterian, Inc. (ATER) Q4 2023 Earnings Call Transcript

Aterian, Inc. (NASDAQ:ATER ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, Investor Relations & Corporate Development Joe Risico - Co-Chief Executive Officer Arturo Rodriguez - Co-Chief Executive Officer Conference Call Participants Mike Zabran - ROTH MKM Brian Kinstlinger - Alliance Global Partners Ilya Grozovsky Thank you for joining us today to discuss Aterian's Third Quarter 2023 Earnings Results. On today's call are Joe Risico and Arturo Rodriguez, our Co-CEOs.